Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

7 Stocks To Buy To Follow in Nancy Pelosi’s Footsteps

Love her or hate her, House Speaker Nancy Pelosi has turned out to be quite an astute sage regarding stocks to buy.

After a Brutal Quarter, Pinterest Stock Will Return to $80

Pinterest's revenues are growing while the company is expanding its shopping features internationally - yet, PINS stock remains undervalued.

SAVA Stock Is a Buy Here Despite the Very Real Risks It Faces

Like with any biotech situation, where it's big possible gains against large possible losses, caution is key. But for investors who approach SAVA stock accordingly, and are able to ride out any future near-term dips in price? It may be a gamble worth taking.

You Don’t Need a Short Squeeze To Enjoy Lemonade Stock

For exposure to the future of insurance technology -- and a novel, pet-centered preventative care package -- give LMND stock a try.

Nio Stock Looks Great on the Strength of This Norway SUV Push

Check the latest delivery stats and you'll surely agree: the drawdown in NIO stock is actually a gift, not a problem.

Tilray Stock Doesn’t Have a Good Path Forward as Revenue Flags

TLRY stock has no realistic path toward increased revenues and stock price. The $4 billion goal doesn't appear achievable.

4 Top Stock Trades for Tuesday: NIO, FB, NKE, PENN

Nio, Facebook, Nike and Penn National Gaming were our top stock trades for Tuesday. Let's look at the charts after a tough session on Monday.

ViacomCBS is Looking Like a Solid Long-Term Growth Pick

If you’ve been holding off on VIAC stock after the big collapse in March, factors are lining up to fuel long-term growth potential.

ReWalk Robotics Is Much, Much More Than a Meme Stock

RWLK stock has popped and flopped on more than one occasion, but it may offer a big opportunity for longer-term investors.

Lucid’s EV Production Kickoff Will Push the Stock Higher

The start of EV production should push LCID stock higher. Shares have an expected return of 42% if Lucid can meet its production targets.

FuboTV Looks Like Good Value Here and Could Be Worth $38

FuboTV looks like good value here as it gains steam with subscriber growth. FUBO stock could rise 58% from here based on the present value of its estimated FCF by 2023.

Best Stocks for 2021: Walgreens Boots Alliance Still A Cheap Stock to Buy

Despite big gains in 2021, WBA stock still looks undervalued at current levels, with potential annual gains of 7% to 15%.

Ocugen Stock Just Needs a Catalyst to Break Free

OCGN stock holders should be patient as the World Health Organization's potential approval of an important vaccine could happen soon.

7 Best Retail Stocks to Buy Now to Profit From the Coming Toy Shortages

Supply chain problems caused by Covid-19 are creating toy shortages. Here are 7 retail stocks to buy that could benefit from this issue.

7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket

Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.

7 Best Cheap Stocks to Buy for October

With fundamentally strong value, these cheap stocks all trade at a forward P/E of less than 10 and look poised for a breakout on the upside.

Traders Should Capitalize After the Sharp Dip in Cloudflare Stock

There's no need to get shaken out of the trade with NET stock as Cloudflare continues to push the boundaries of internet speed and security.

Nvidia Commands Respect on Wall Street

The fundamental argument for NVDA stock is a slam dunk. With a bit of common sense, it becomes easy to invest in this winner.

Accept Volatility in Moderna As It Should Prevail in Time

There's no need to abandon MRNA stock now as Moderna remains an aggressive pioneer in advancing mRNA therapeutics.